FDA to be updated with specific INN name coverage for business development, investment, and market access teams
The FDA has approved Dermacure, a novel anti-inflammatory drug, to treat atopic dermatitis, promising significant relief for patients suffering from this chronic skin condition.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
